METTL14 and neoplasm: LcL shCr, LcL shMETTL14, LcL shEBNA3C and LcL shMETTL14 plus shEBNA3C were subcutaneously injected into NOD-SCID mice to assess the effect of knock-down METTL14 or EBNA3C on tumor growth.